NCT01654575View on ClinicalTrials.gov

Methotrexate in Symptomatic Knee Osteoarthritis

NACompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

January 31, 2012

Conditions
Osteoarthritis
Interventions
DRUG

Methotrexate

Methotrexate 25mg/week for 16 weeks

DRUG

Placebo

Placebo tablets once a week for 16 weeks

Trial Locations (1)

Unknown

Faculty of Medicine, University of Alexandria, Alexandria

All Listed Sponsors
lead

University of Alexandria

OTHER

NCT01654575 - Methotrexate in Symptomatic Knee Osteoarthritis | Biotech Hunter | Biotech Hunter